Chemodex

Glycyrrhizic acid ammonium salt

CHF 75.00
In stock
CDX-G0215-G02525 gCHF 75.00
CDX-G0215-G100100 gCHF 272.00
More Information
Product Details
Synonyms Glycyrrhizin; 3-O-(2-O-β-D-Glucopyranuronosyl-α-D-glucopyranuronosyl)-18β-glycyrrhetinic acid ammonium salt; Monoammonium glycyrrhizinate; NSC 2800; NSC 35348
Product Type Chemical
Properties
Formula

C42H62O16 . NH3

MW 839.96
CAS 53956-04-0
RTECS LZ6500000
Source/Host Chemicals Plant
Purity Chemicals ≥98% (Titr.)
Appearance White powder.
Solubility Soluble in DMSO (10mg/ml). Slightly soluble in water (1mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key ILRKKHJEINIICQ-IERXZFCASA-N
Smiles O=C(O)[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](C(O)=O)O[C@@H]2O[C@H]3C(C)(C)[C@@](CC[C@]([C@@](CC[C@]4(C)[C@@]5([H])C[C@@](C)(C(O)=O)CC4)(C)C5=C6)(C)[C@]7([H])C6=O)([H])[C@]7(C)CC3)O1.N
Shipping and Handling
Shipping AMBIENT
Short Term Storage +20°C
Long Term Storage +4°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description

Glycyrrhizic acid is a natural triterpenoid saponin. It is an agonist of the human sweet taste receptor and is used as a flavorant. Glycyrrhizic acid has diverse biological activities, including antioxidant, anti-inflammatory, antidiabetic, anticancer, antimicrobial, hepatoprotective, neuroprotective and antiviral actions. Glycyrrhizic acid has been shown to be a 11-β-hydroxysteroid dehydrogenase inhibitor, a functional inhibitor of HMGB1 and a highly selective and competitive inhibitor of kynurenine aminotransferase 2 (KAT2). It can enhance GLP-1 secretion through TGR5 activation and has an anti-inflammatory effect by attenuating the generation of excessive NO, PGE(2), and ROS and by suppressing the expression of pro-inflammatory genes through the inhibition of NF-κ and PI3K activity. It has anti-angiogenic and apoptosis inducing properties. In addition, due to its amphiphilic nature glycyrrhizic acid is able to form self-associates in aqueous and non-aqueous media, as well as water soluble complexes with a wide range of lipophilic drugs. It has been identified as promising carrier material for anticancer therapy, due to its anti-cancer-related pharmacological activities, such as broad-spectrum anti-cancer ability, resistance to the tissue toxicity caused by chemotherapy and radiation, drug absorption enhancing effects and anti-multidrug resistance (MDR) mechanisms.

Product References

(1) R. Pompei, et al.; Experientia 36, 304 (1980) | (2) N.M. Gandhi, et al.; J. Radiat. Res. 45, 461 (2004) | (3) C.Y. Wang, et al.; J. Agric. Food Chem. 59, 7726 (2011) | (4) Y.Y. Chia, et al.; Eur. J. Pharmacol. 677, 197 (2012) | (5) K.J. Kim, et al.; Phytother. Res. 27, 841 (2013) | (6) F.S. Chueh, et al.; Oncol. Rep. 28, 2069 (2012) | (7) E.S. Ramli, et al.; J. Bone Miner. Metab. 31, 262 (2013) | (8) L.J. Ming & A.C. Yin; Nat. Prod. Commun. 8, 415 (2013) (Review) | (9) A. Lau, et al.; Am. J. Nephrol. 40, 84 (2014) | (10) H.S. Cheng, et al.; Nat. Prod. Bioprospect. 4, 325 (2014) | (11) Y. Ohtsu, et al.; Mol. Cell. Endocrinol. 394, 70 (2014) | (12) L. Wang, et al.; Acta Pharmac. Sin. B 5, 310 (2015) | (13) S. Ojha, et al.; Neurotox. Res. 29, 275 (2016) | (14) L.Y. Wang, et al.; Biomed. Pharmacother. 95, 599 (2017) | (15) Z.G. Sun, et al.; Mini Rev. Med. Chem. 19, 826 (2019) (Review) | (16) O.Y. Selyutina & N.E. Polyakov; Int. J. Pharm. 559, 271 (2019) (Review) | (17) Y. Yoshida, et al.; Sci. Rep. 9, 10243 (2019)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.